Uncategorized - Express Pharma

Alembic Pharma gets form 483 with five procedural observations by USFDA

JB Pharma announces ESG commitments with launch of third sustainability report

Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial)

FDA updates guidance to address spread of misinformation

Total prevalent cases of osteoporosis to cross 58.05 mn in 7MM by 2033: GlobalData

Asahi Kasei Medical completes new assembly plant for Planova virus removal filters

Taro shareholders approve merger with Sun Pharma

The trailblazers among us: honouring India’s clinical research professionals

Alembic Pharmaceuticals receives an EIR for its oncology formulation facility

Decoding the skirmish over revised Schedule M